東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Linked to FindBook

Google Book

Amazon

博客來

Obesity and lung disease = a guide to pathophysiology, evaluation, and management /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Obesity and lung disease/ edited by Anne E. Dixon, Erick Forno.
Reminder of title:	a guide to pathophysiology, evaluation, and management /
other author:	Dixon, Anne E.
Published:	Cham :Springer International Publishing : : 2024.,
Description:	ix, 411 p. :ill., digital ;24 cm.
[NT 15003449]:	SECTION I: Pathophysiology of Obesity and Lung Disease -- Airway Physiology and Lung Function -- Immune Function and Host Defense -- The Microbiome -- Metabolic Dysregulation -- Genetics and Genomics -- Diet and Nutrition -- SECTION II: Obesity and Respiratory Diseases -- Obstructive Sleep Apnea -- Obesity Hypoventilation Syndrome -- Asthma: Epidemiology and Clinical Presentation -- Asthma: Endotypes and Mechanisms -- Asthma: Management -- Chronic Obstructive Pulmonary Disease -- Pulmonary Hypertension -- Thromboembolic Disease -- Lung Transplant -- Respiratory Infections (Including COVID19) -- Lung Health in Pediatrics -- SECTION III: Obesity and Critical Care -- ALI and ARDS -- Mechanical Ventilation -- COVID19 in the ICU.
Contained By:	Springer Nature eBook
Subject:	Lungs - Diseases. -
Online resource:	https://doi.org/10.1007/978-3-031-52696-1
ISBN:	9783031526961

Obesity and lung disease = a guide to pathophysiology, evaluation, and management /
Obesity and lung diseasea guide to pathophysiology, evaluation, and management /[electronic resource] :edited by Anne E. Dixon, Erick Forno. - Second edition. - Cham :Springer International Publishing :2024. - ix, 411 p. :ill., digital ;24 cm. - Respiratory medicine,2197-7380. - Respiratory medicine..

SECTION I: Pathophysiology of Obesity and Lung Disease -- Airway Physiology and Lung Function -- Immune Function and Host Defense -- The Microbiome -- Metabolic Dysregulation -- Genetics and Genomics -- Diet and Nutrition -- SECTION II: Obesity and Respiratory Diseases -- Obstructive Sleep Apnea -- Obesity Hypoventilation Syndrome -- Asthma: Epidemiology and Clinical Presentation -- Asthma: Endotypes and Mechanisms -- Asthma: Management -- Chronic Obstructive Pulmonary Disease -- Pulmonary Hypertension -- Thromboembolic Disease -- Lung Transplant -- Respiratory Infections (Including COVID19) -- Lung Health in Pediatrics -- SECTION III: Obesity and Critical Care -- ALI and ARDS -- Mechanical Ventilation -- COVID19 in the ICU.

This new edition provides a fully updated guide to obesity's relation to lung disease. Over forty percent of the U.S. population is obese, and obesity is increasing in much of the world. Obesity has a major impact on health conditions such as diabetes and cardiovascular disease. The effects of obesity on lung disease have drawn increasing attention in recent years. Furthermore, the COVID pandemic has dramatically illustrated how obesity affects respiratory disease, constitutes a major risk factor for COVID-19, and presents challenges to pulmonary care in the ICU. Obesity changes physiology, immune and metabolic function, and is associated with changes in diet and the microbiome, all of which combine to have a major impact on the pathogenesis of respiratory diseases. Obesity is thus a risk factor for many respiratory diseases such as asthma, pulmonary hypertension, thromboembolic disease, obstructive sleep apnea and ARDS. Obesity also complicates the management of many other respiratory diseases and conditions such as COPD, thromboembolic disease, and the care of the critically ill patient. The objectives of this book are three-fold: To review how physiological, immune and metabolic factors might contribute to lung disease. To discuss the impact of obesity on common lung diseases To outline important considerations in the management of critically ill obese patients. There have been major advances in our understanding of the relationship between obesity and lung disease since the first edition in 2013, in addition to the major lessons learned about the importance of obesity during the COVID-19 pandemic. This has led to the addition of eight new chapters on topics such as, the microbiome, lung transplant, and COVID-19 in the ICU. This is an ideal guide for all clinicians taking care of patients with pulmonary and critical care diseases, as well as basic and translational scientists interested in how obesity affects respiratory health.

ISBN: 9783031526961

Standard No.: 10.1007/978-3-031-52696-1doiSubjects--Topical Terms:

1006034
Lungs
--Diseases.

LC Class. No.: RC756 / .O24 2024

Dewey Class. No.: 616.24

Obesity and lung disease = a guide to pathophysiology, evaluation, and management /
LDR:03786nmm a2200349 a 4500 001 2371769
003 DE-He213
005 20240528104005.0
006 m d
007 cr nn 008maaau
008 241127s2024 sz s 0 eng d
020 $a 9783031526961 $q (electronic bk.)
020 $a 9783031526954 $q (paper)
024 7 $a 10.1007/978-3-031-52696-1 $2 doi
035 $a 978-3-031-52696-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC756 $b .O24 2024
072 7 $a MJL $2 bicssc
072 7 $a MED079000 $2 bisacsh
072 7 $a MJL $2 thema
082 0 4 $a 616.24 $2 23
090 $a RC756 $b .O12 2024
245 0 0 $a Obesity and lung disease $h [electronic resource] : $b a guide to pathophysiology, evaluation, and management / $c edited by Anne E. Dixon, Erick Forno.
250 $a Second edition.
260 $a Cham : $b Springer International Publishing : $b Imprint: Humana, $c 2024.
300 $a ix, 411 p. : $b ill., digital ; $c 24 cm.
490 1 $a Respiratory medicine, $x 2197-7380
505 0 $a SECTION I: Pathophysiology of Obesity and Lung Disease -- Airway Physiology and Lung Function -- Immune Function and Host Defense -- The Microbiome -- Metabolic Dysregulation -- Genetics and Genomics -- Diet and Nutrition -- SECTION II: Obesity and Respiratory Diseases -- Obstructive Sleep Apnea -- Obesity Hypoventilation Syndrome -- Asthma: Epidemiology and Clinical Presentation -- Asthma: Endotypes and Mechanisms -- Asthma: Management -- Chronic Obstructive Pulmonary Disease -- Pulmonary Hypertension -- Thromboembolic Disease -- Lung Transplant -- Respiratory Infections (Including COVID19) -- Lung Health in Pediatrics -- SECTION III: Obesity and Critical Care -- ALI and ARDS -- Mechanical Ventilation -- COVID19 in the ICU.
520 $a This new edition provides a fully updated guide to obesity's relation to lung disease. Over forty percent of the U.S. population is obese, and obesity is increasing in much of the world. Obesity has a major impact on health conditions such as diabetes and cardiovascular disease. The effects of obesity on lung disease have drawn increasing attention in recent years. Furthermore, the COVID pandemic has dramatically illustrated how obesity affects respiratory disease, constitutes a major risk factor for COVID-19, and presents challenges to pulmonary care in the ICU. Obesity changes physiology, immune and metabolic function, and is associated with changes in diet and the microbiome, all of which combine to have a major impact on the pathogenesis of respiratory diseases. Obesity is thus a risk factor for many respiratory diseases such as asthma, pulmonary hypertension, thromboembolic disease, obstructive sleep apnea and ARDS. Obesity also complicates the management of many other respiratory diseases and conditions such as COPD, thromboembolic disease, and the care of the critically ill patient. The objectives of this book are three-fold: To review how physiological, immune and metabolic factors might contribute to lung disease. To discuss the impact of obesity on common lung diseases To outline important considerations in the management of critically ill obese patients. There have been major advances in our understanding of the relationship between obesity and lung disease since the first edition in 2013, in addition to the major lessons learned about the importance of obesity during the COVID-19 pandemic. This has led to the addition of eight new chapters on topics such as, the microbiome, lung transplant, and COVID-19 in the ICU. This is an ideal guide for all clinicians taking care of patients with pulmonary and critical care diseases, as well as basic and translational scientists interested in how obesity affects respiratory health.
650 0 $a Lungs $x Diseases. $3 1006034
650 0 $a Obesity. $3 525736
650 1 4 $a Pneumology. $3 3596538
650 2 4 $a Primary Care Medicine. $3 894341
650 2 4 $a Intensive Care Medicine. $3 3538866
700 1 $a Dixon, Anne E. $3 3718024
700 1 $a Forno, Erick. $3 3445684
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Respiratory medicine. $3 1566170
856 4 0 $u https://doi.org/10.1007/978-3-031-52696-1
950 $a Medicine (SpringerNature-11650)